Skip to main content

Exteriors of the Sun Life Financial office building at 150 King St. West photographed Feb. 24 2014.

Fred Lum/Fred Lum/The Globe and Mail

StockReports+ is a Thomson Reuters service that helps investors pick equities by simplifying the process of evaluating stocks, finding new trading ideas, and understanding trends affecting markets and industries. Globe Unlimited subscribers get unlimited access to these reports from about 7,000 companies, which normally retail for $25 each.

Sun Life Financial Inc. shares are well off their 52-week highs, despite easily surpassing analysts' expectations in reporting first-quarter earnings earlier this month. Insurance companies can benefit from rising interest rates, but they've generally fallen this year despite widespread expectations to the contrary. This StockReports+ analysis suggests now may be good time to consider the stock.

StockReports+ gives each stock an average score that combines the quantitative analysis of six widely-used investment decision-making tools: earnings, fundamentals, relative valuation, risk, price momentum and insider trading. The score for Sun Life Financial rose two points in the past week to a perfect 10, a three-year high.

Story continues below advertisement

Read more in this comprehensive report.

Read other reports here.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter